318 related articles for article (PubMed ID: 23680109)
1. Mycoplasma hyopneumoniae: from disease to vaccine development.
Simionatto S; Marchioro SB; Maes D; Dellagostin OA
Vet Microbiol; 2013 Aug; 165(3-4):234-42. PubMed ID: 23680109
[TBL] [Abstract][Full Text] [Related]
2. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
Park SJ; Seo HW; Park C; Chae C
Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of piglets up to 1 week of age with a single-dose Mycoplasma hyopneumoniae vaccine induces protective immunity within 2 weeks against virulent challenge in the presence of maternally derived antibodies.
Wilson S; Van Brussel L; Saunders G; Runnels P; Taylor L; Fredrickson D; Salt J
Clin Vaccine Immunol; 2013 May; 20(5):720-4. PubMed ID: 23486417
[TBL] [Abstract][Full Text] [Related]
4. Acclimation strategies in gilts to control Mycoplasma hyopneumoniae infection.
Garza-Moreno L; Segalés J; Pieters M; Romagosa A; Sibila M
Vet Microbiol; 2018 Jun; 219():23-29. PubMed ID: 29778201
[TBL] [Abstract][Full Text] [Related]
5. A concise review of vaccines against Mycoplasma hyopneumoniae.
Tao Y; Shu J; Chen J; Wu Y; He Y
Res Vet Sci; 2019 Apr; 123():144-152. PubMed ID: 30665029
[TBL] [Abstract][Full Text] [Related]
6. Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.
Maes D; Boyen F; Devriendt B; Kuhnert P; Summerfield A; Haesebrouck F
Vet Res; 2021 May; 52(1):67. PubMed ID: 33964969
[TBL] [Abstract][Full Text] [Related]
7. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
[TBL] [Abstract][Full Text] [Related]
8. Blending of a conventional Mycoplasma hyopneumoniae vaccine with a positive marker: tracking of immunised pigs by peptide-specific antibodies raised to the marker component.
Walders B; Raschke A; Neugebauer M; Geuther E; Bertling W; Reiser C; Buck A; Strich S; Hess J
Res Vet Sci; 2005 Apr; 78(2):135-41. PubMed ID: 15563920
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies.
Hillen S; von Berg S; Köhler K; Reinacher M; Willems H; Reiner G
Prev Vet Med; 2014 Mar; 113(4):580-8. PubMed ID: 24485705
[TBL] [Abstract][Full Text] [Related]
10. A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.
de Oliveira NR; Jorge S; Gomes CK; Rizzi C; Pacce VD; Collares TF; Monte LG; Dellagostin OA
Vet Microbiol; 2017 Mar; 201():146-153. PubMed ID: 28284602
[TBL] [Abstract][Full Text] [Related]
11. Development of Mycoplasma hyopneumoniae Recombinant Vaccines.
Marchioro SB; Simionatto S; Dellagostin O
Methods Mol Biol; 2016; 1404():39-50. PubMed ID: 27076288
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
13. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
Moreau IA; Miller GY; Bahnson PB
Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs.
Arsenakis I; Panzavolta L; Michiels A; Del Pozo Sacristán R; Boyen F; Haesebrouck F; Maes D
BMC Vet Res; 2016 Mar; 12():63. PubMed ID: 27025924
[TBL] [Abstract][Full Text] [Related]
15. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
[TBL] [Abstract][Full Text] [Related]
16. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
17. Control of Mycoplasma hyopneumoniae infections in pigs.
Maes D; Segales J; Meyns T; Sibila M; Pieters M; Haesebrouck F
Vet Microbiol; 2008 Jan; 126(4):297-309. PubMed ID: 17964089
[TBL] [Abstract][Full Text] [Related]
18. A field evaluation of two vaccines against Mycoplasma hyopneumoniae infection in pigs.
Kristensen CS; Vinther J; Svensmark B; Bækbo P
Acta Vet Scand; 2014 Apr; 56(1):24. PubMed ID: 24739629
[TBL] [Abstract][Full Text] [Related]
19. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
[TBL] [Abstract][Full Text] [Related]
20. Application of a sIgA-ELISA method for differentiation of Mycoplasma hyopneumoniae infected from vaccinated pigs.
Bai Y; Gan Y; Hua LZ; Nathues H; Yang H; Wei YN; Wu M; Shao GQ; Feng ZX
Vet Microbiol; 2018 Sep; 223():86-92. PubMed ID: 30173757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
